[Ethics, politics, and rights in pharmacogenomics].
The article focuses in three aspects. Firstly, distinctions are drawn between pharmacogenetic testing and other types of genetic test, and the advantages of pharmacogenomics for individuals and society generally are discussed. Secondly, the article examines some of the ethical problems raised by research in and clinical aspects of pharmacogenomics. Thirdly and lastly, a number of risk potentially associated with this new technology are discussed.